The way out is for these companies to also educate the public about how to use their autoinjectors. If the half dozen medium-small companies who marketed the Ep

The way out is for these companies to also educate the public about how to use their autoinjectors. If the half dozen medium-small companies who marketed the EpiPen managed it well before Merck got involved, surely almost anyone else can do the same (if they are not too lazy to do the basic due diligence).